Stay updated on Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedNew study documents with associated dates and file sizes are now linked in the Study Details page, along with updated verification timestamps from the sponsor team. This addition provides access to key consent and protocol materials and contextual metadata.SummaryDifference53%

- Check17 days agoChange DetectedThe page shows revision v3.6.5, replacing v3.6.4, indicating a new version of the page. It's a metadata update rather than a change to study content or functionality.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page. This indicates a minor content/metadata update and does not change any study details.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page revision tag was updated to v3.6.3, replacing the previous version v3.6.2. This appears to be a minor maintenance update that does not modify the study content or patient-facing information.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision tag on the page was updated to v3.6.2, replacing the previous v3.6.0. This indicates an update to the study documents or protocol associated with the clinical trial record.SummaryDifference0.1%

- Check74 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study); an existing header style for Intervention/Treatment was updated, while the old Revision: v3.5.5 was removed and Revision: v3.6.0 was added.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.